Last reviewed · How we verify
Epitizid (epitizide)
Epitizid (generic name: epitizide) is a epitizide drug. It is currently in unknown development for Hypertensive disorder.
Epitizide is thought to work by interacting with a specific target to produce a therapeutic effect.
Epitizide is a small molecule diuretic. It is often used in combination with triamterene.
At a glance
| Generic name | epitizide |
|---|---|
| Drug class | epitizide |
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
Think of it like a key fitting into a lock. Epitizide is like the key, and the target is like the lock. When the key fits into the lock, it helps to turn off the signals that make blood pressure go up, which can help to lower blood pressure and treat hypertensive disorder.
Approved indications
- Hypertensive disorder
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epitizid CI brief — competitive landscape report
- Epitizid updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Epitizid
What is Epitizid?
How does Epitizid work?
What is Epitizid used for?
What is the generic name of Epitizid?
What drug class is Epitizid in?
What development phase is Epitizid in?
Related
- Drug class: All epitizide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Hypertensive disorder
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing